- Home
- RPRX vs NVT Comparison
RPRX vs NVT Comparison
Compare RPRX & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | NVT |
|---|---|---|
| Founded | 1996 | 1903 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7B | 16.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | NVT |
|---|---|---|
| Price | $40.54 | $110.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $45.75 | ★ $107.58 |
| AVG Volume (30 Days) | ★ 3.4M | 1.6M |
| Earning Date | 02-11-2026 | 02-06-2026 |
| Dividend Yield | ★ 2.33% | 0.76% |
| EPS Growth | N/A | ★ 6.36 |
| EPS | 1.75 | ★ 3.64 |
| Revenue | $2,349,844,000.00 | ★ $3,578,600,000.00 |
| Revenue This Year | $37.66 | $28.70 |
| Revenue Next Year | $2.34 | $14.97 |
| P/E Ratio | ★ $23.06 | $30.32 |
| Revenue Growth | 3.70 | ★ 21.54 |
| 52 Week Low | $29.66 | $41.71 |
| 52 Week High | $41.70 | $117.52 |
Technical Indicators
Market Signals| Indicator | RPRX | NVT |
|---|---|---|
| Relative Strength Index (RSI) | 59.05 | 56.18 |
| Support Level | $38.86 | $109.26 |
| Resistance Level | $40.58 | $115.95 |
| Average True Range (ATR) | 0.76 | 3.84 |
| MACD | 0.01 | 0.49 |
| Stochastic Oscillator | 58.63 | 61.04 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.